sulfinpyrazone has been researched along with Disseminated Intravascular Coagulation in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Disseminated Intravascular Coagulation: A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ludlam, CA | 1 |
| Allan, N | 1 |
| Blandford, RB | 1 |
| Dowdle, R | 1 |
| Bentley, NJ | 1 |
| Bloom, AL | 1 |
1 other study available for sulfinpyrazone and Disseminated Intravascular Coagulation
| Article | Year |
|---|---|
Platelet and coagulation function in patients with abnormal cardiac valves treated with sulphinpyrazone.
Topics: Adult; Aged; Anticoagulants; beta-Thromboglobulin; Cell Survival; Disseminated Intravascular Coagula | 1981 |